Latest filing published 03 Feb 2026 for HERON THERAPEUTICS, INC. /DE/. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Craig A. Johnson span 4 companies, the busiest being Heron Therapeutics, Inc. /DE/, Mirati Therapeutics, Inc. and Aurinia Pharmaceuticals Inc. Between 21 June 2021 and 30 January 2026, the trades on record add up to 16 filings.
No open-market purchase appears, only 3 sales worth €7,969. Besides market trades, the filings include 10 share grants and 1 option exercise.
The latest filing, published on 3 February 2026, reports a share grant in Heron Therapeutics, Inc. /DE/. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations